Skip to main content
OpenTrials

Clinical trial condition

Immune Thrombocytopenia

Explore clinical trials studying Immune Thrombocytopenia. Study availability and eligibility vary by location and protocol.

96 public trials 33 recruiting studies
Refine in advanced search Browse all conditions

Immune Thrombocytopenia trial results

Active, not recruiting

Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

NCT04562766

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • University of Southern California_Investigational Site Number 84024 Los Angeles, California, United States
  • UCSF Benioff Children's Hospital San Francisco_Investigational Site Number 84020 San Francisco, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center_Investigational Site Number 84037 Torrance, California, United States
  • The Oncology Institute of Hope and Innovation_Investigational Site Number 84031 Whittier, California, United States
View all 155 locations
View Trial Details
Completed

An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias (RUBY-4)

NCT05757570

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +22 more
Locations
  • Investigational Site (230) Los Angeles, California, United States
  • Investigational Site (401) Washington D.C., District of Columbia, United States
  • Investigational Site (419) Cooper City, Florida, United States
  • Investigational Site (425) Miami, Florida, United States
View all 44 locations
View Trial Details
Completed

Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP

NCT05369208

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Sobi Site 105 Toyohashi, Aichi-ken, Japan
  • Sobi Site 110 Tōon, Ehime, Japan
  • Sobi Site 118 Iizuka-shi, Fukuoka, Japan
  • Sobi Site 116 Kitakyushu, Fukuoka, Japan
View all 19 locations
View Trial Details
Completed

Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months

NCT04516967

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Site 112 Phoenix, Arizona, United States
  • Site 103 Long Beach, California, United States
  • Site 119 Orange, California, United States
  • Site 109 Sacramento, California, United States
View all 62 locations
View Trial Details
Completed

A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)

NCT03395210

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Bleeding and Clotting Disorders Institute- Site Number : 1087 Peoria, Illinois, United States
  • RCCA MC LLC- Site Number : 1091 Bethesda, Maryland, United States
  • Massachusetts General Hospital Cancer Center- Site Number : 1092 Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center- Site Number : 1099 Boston, Massachusetts, United States
View all 31 locations
View Trial Details

Related conditions